WSJ Pro Venture Capital Coverage of Horizon Investment in GNS Highlights Application of Precision Medicine to Population Health

Health insurers that have struggled to curb rates of chronic illnesses are turning for help to innovative data-analysis startups Read the complete story here.

GNS Healthcare Announces Investment by Horizon Healthcare Services, Inc. to Expand Strategic Partnership Focused on Precision Medicine in Population Health

CAMBRIDGE, Mass. – May 23, 2016 – GNS Healthcare (GNS), a leading precision medicine company that applies causal machine learning technology to match health interventions to individual patients and discover new target intervention pathways, today announced an investment by Horizon Healthcare Services, Inc. (New Jersey). The investment supports a strategic collaboration between the companies and […]

BioTelemetry, Inc. (NASDAQ:BEAT) Appoints Colin Hill to Board of Directors

GNS CEO Colin Hill has been named to the Board of Directors of BioTelemetry, Inc., the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care. “Mr. Hill’s impressive leadership experience in machine learning in the precision medicine and managed care industries will […]

GNS Healthcare Study with Pfizer Reveals Discovery of Novel Clinical Risk Factors Driving Progression to Type 2 Diabetes and Prediabetes

Published by the Journal of Diabetes Science and Technology, Discoveries Result From Computer Models Created From EHR Data and Causal Machine Learning Technology CAMBRIDGE, Mass. – Feb. 29, 2016 – GNS Healthcare (GNS), a leading precision medicine company that applies causal machine learning technology to match health interventions to individual patients and discover new intervention […]

Alliance for Clinical Trials in Oncology and GNS Healthcare Launch Big Data Initiative to Transform Metastatic Colorectal Cancer Treatment

Partners to Apply Causal Machine Learning and Simulation to Combination Treatment Regimens to Discover Biomarkers of Clinical Response to Treatment CHICAGO, Ill. and CAMBRIDGE, Mass. – Dec. 15, 2015 – The Alliance for Clinical Trials in Oncology (the Alliance), one of the five cooperative research groups in the United States sponsored by the National Cancer […]

MobiHealthNews: GNS Healthcare raises $10M for precision medicine analytics

Cambridge, Massachusetts-based GNS Healthcare, which has developed an analytics tool for precision medicine and population health, raised $10 million from Celgene Corporation, Alexandria Real Estate Equities, and Gi Global Health Fund. Existing investors Cambia Health Solutions, Heritage Provider Network, and Mitsui USA, the US subsidiary of Japan’s Mitsui & Co, also participated. This brings the company’s total funding […]

GNS Healthcare Secures $10M Series C Financing to Accelerate Development of New, Data-Driven Solutions at the Intersection of Precision Medicine and Population Health

New Investors Celgene Corporation, Alexandria Real Estate Equities, and Gi Global Health Fund LP Join Cambia Health Solutions, Heritage Provider Network, Mitsui CAMBRIDGE, Mass. – Dec. 8, 2015 – GNS Healthcare (GNS), a leading precision medicine company that applies causal machine learning technology to match health interventions to individual patients and discover new target intervention pathways, […]

BioIT World: GNS Healthcare Announces $10M Financing, MMRF Study Results

GNS Healthcare announced a $10M Series C financing round today. New investors in this round—Celgene Corporation, Alexandria Real Estate Equities, and Gi Global Health Fund LP—join previous investors including Cambia Health Solutions, California’s Heritage Provider Network, and Japan’s Mitsui & Co. U.S. subsidiary (“Mitsui USA”). GNS builds cloud-based big data solutions for precision medicine and […]

GenomeWeb: GNS Healthcare Lands $10M Series C Financing

NEW YORK (GenomeWeb) — GNS Healthcare has completed a $10 million Series C financing round, led by new investors including Celgene, Alexandria Real Estate Equities, and Gi Global Health Fund. The new investors joined prior investors in the round, including Cambia Health Solutions, Heritage Provider Network, and Mitsui USA. The firm said it would use […]

PharmiWeb.com: New Data at ASH 2015 from the Multiple Myeloma Research Foundation

The Multiple Myeloma Research Foundation (MMRF) is presenting today new data from the MMRF CoMMpass StudySM – the most comprehensive long-term genomic study ever conducted in myeloma and one that may significantly advance the understanding of multiple myeloma. The data provide significant insights into the genetics of multiple myeloma and the potential association to patient […]